NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Francisco Marty
Harvard University - Cambridge / United States
Medical and Health Sciences / Infectious Diseases
AD Scientific Index ID: 4512352
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Francisco Marty's MOST POPULAR ARTICLES
1-)
Remdesivir for 5 or 10 days in patients with severe Covid-19JD Goldman, DCB Lye, DS Hui, KM Marks, R Bruno, R Montejano, ...New England Journal of Medicine 383 (19), 1827-1837, 202013272020
2-)
Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trialCD Spinner, RL Gottlieb, GJ Criner, JRA López, AM Cattelan, ...Jama 324 (11), 1048-1057, 202011182020
3-)
Early remdesivir to prevent progression to severe Covid-19 in outpatientsRL Gottlieb, CE Vaca, R Paredes, J Mera, BJ Webb, G Perez, G Oguchi, ...New England Journal of Medicine 386 (4), 305-315, 20228442022
4-)
Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantationFM Marty, P Ljungman, RF Chemaly, J Maertens, SS Dadwal, RF Duarte, ...New England Journal of Medicine 377 (25), 2433-2444, 201711012017
5-)
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisFM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...The Lancet infectious diseases 16 (7), 828-837, 20167112016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept